Chongqing Sansheng Building Materials Co Ltd (002742) - Net Assets

Latest as of March 2026: CN¥230.59 Million CNY ≈ $33.74 Million USD

Based on the latest financial reports, Chongqing Sansheng Building Materials Co Ltd (002742) has net assets worth CN¥230.59 Million CNY (≈ $33.74 Million USD) as of March 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (CN¥1.13 Billion ≈ $164.73 Million USD) and total liabilities (CN¥895.14 Million ≈ $130.99 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check 002742 tangible net worth ratio to evaluate the tangible quality of the company's equity base.

Key Net Assets Metrics

Metric Value
Current Net Assets CN¥230.59 Million
% of Total Assets 20.48%
Annual Growth Rate -3.59%
5-Year Change -81.78%
10-Year Change -82.32%
Growth Volatility 48.74

Chongqing Sansheng Building Materials Co Ltd - Net Assets Trend (2011–2025)

This chart illustrates how Chongqing Sansheng Building Materials Co Ltd's net assets have evolved over time, based on quarterly financial data. See how many days can Chongqing Sansheng Building Materials Co fund operations to measure how many days the company can operate on defensive assets alone.

Annual Net Assets for Chongqing Sansheng Building Materials Co Ltd (2011–2025)

The table below shows the annual net assets of Chongqing Sansheng Building Materials Co Ltd from 2011 to 2025. For live valuation and market cap data, see 002742 stock market capitalisation.

Year Net Assets Change
2025-12-31 CN¥239.30 Million
≈ $35.02 Million
+204.49%
2024-12-31 CN¥-229.01 Million
≈ $-33.51 Million
-141.06%
2023-12-31 CN¥557.76 Million
≈ $81.62 Million
-43.75%
2022-12-31 CN¥991.65 Million
≈ $145.11 Million
-24.49%
2021-12-31 CN¥1.31 Billion
≈ $192.17 Million
-25.22%
2020-12-31 CN¥1.76 Billion
≈ $256.98 Million
-2.82%
2019-12-31 CN¥1.81 Billion
≈ $264.43 Million
+2.91%
2018-12-31 CN¥1.76 Billion
≈ $256.96 Million
+7.45%
2017-12-31 CN¥1.63 Billion
≈ $239.15 Million
+20.76%
2016-12-31 CN¥1.35 Billion
≈ $198.04 Million
+9.94%
2015-12-31 CN¥1.23 Billion
≈ $180.14 Million
+78.89%
2014-12-31 CN¥688.15 Million
≈ $100.70 Million
+15.59%
2013-12-31 CN¥595.34 Million
≈ $87.12 Million
+18.13%
2012-12-31 CN¥503.96 Million
≈ $73.75 Million
+26.28%
2011-12-31 CN¥399.08 Million
≈ $58.40 Million
--

Equity Component Analysis

This analysis shows how different components contribute to Chongqing Sansheng Building Materials Co Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have decreased by 1042.7% over the analyzed period, potentially due to dividend distributions or operating losses.

Current Equity Component Breakdown (December 2025)

Component Amount Percentage
Other Components CN¥1.44 Billion 854.76%
Total Equity CN¥168.38 Million 100.00%

Chongqing Sansheng Building Materials Co Ltd Competitors by Market Cap

The table below lists competitors of Chongqing Sansheng Building Materials Co Ltd ranked by their market capitalization.

Company Market Cap
Simei Media Co Ltd
SHE:002712
$358.40 Million
Maanshan Iron & Steel Company Limited
F:YM9A
$358.60 Million
GUOMAI Culture & Media Co. Ltd.
SHE:301052
$358.69 Million
Berjaya Corporation Bhd
KLSE:3395
$358.74 Million
Acme Electronics
TWO:8121
$358.34 Million
Gladstone Investment Corporation 8.00% Notes due 2028
NASDAQ:GAINL
$358.34 Million
Bsm Chemical Co Ltd
SHE:300796
$358.30 Million
Shaanxi Meibang Pharmaceutical Group Co Ltd
SHG:605033
$358.29 Million

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Chongqing Sansheng Building Materials Co Ltd's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2024 to 2025, total equity changed from -411,810,939 to 168,380,544, a change of 580,191,483.
  • Net loss of 419,682,692 reduced equity.
  • Dividend payments of 17,078,707 reduced retained earnings.
  • Other factors increased equity by 1,016,952,881.

Equity Change Factors (2024 to 2025)

Factor Impact Contribution
Net Income CN¥-419.68 Million -249.25%
Dividends Paid CN¥17.08 Million -10.14%
Other Changes CN¥1.02 Billion +603.96%
Total Change CN¥- %

Book Value vs Market Value Analysis

This analysis compares Chongqing Sansheng Building Materials Co Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

  • Current price-to-book ratio: 14.54x
  • The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
  • The price-to-book ratio has increased from 2.91x to 14.54x over the analyzed period, suggesting growing market confidence.

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
2011-12-31 CN¥1.23 CN¥3.58 x
2012-12-31 CN¥1.55 CN¥3.58 x
2013-12-31 CN¥1.83 CN¥3.58 x
2014-12-31 CN¥2.09 CN¥3.58 x
2015-12-31 CN¥2.97 CN¥3.58 x
2016-12-31 CN¥2.99 CN¥3.58 x
2017-12-31 CN¥3.30 CN¥3.58 x
2018-12-31 CN¥3.49 CN¥3.58 x
2019-12-31 CN¥3.60 CN¥3.58 x
2020-12-31 CN¥3.51 CN¥3.58 x
2021-12-31 CN¥2.59 CN¥3.58 x
2022-12-31 CN¥1.87 CN¥3.58 x
2023-12-31 CN¥0.80 CN¥3.58 x
2024-12-31 CN¥-0.95 CN¥3.58 x
2025-12-31 CN¥0.25 CN¥3.58 x

Capital Efficiency Dashboard

This dashboard shows how efficiently Chongqing Sansheng Building Materials Co Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): -249.25%
  • The company may be facing challenges in efficiently utilizing shareholder equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: -46.64%
  • • Asset Turnover: 0.75x
  • • Equity Multiplier: 7.10x
  • Recent ROE (-249.25%) is below the historical average (-21.55%), suggesting potential challenges in capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
2011 21.86% 10.29% 1.16x 1.84x CN¥47.32 Million
2012 20.33% 9.65% 1.20x 1.76x CN¥52.08 Million
2013 17.27% 8.74% 0.91x 2.17x CN¥43.15 Million
2014 14.81% 7.95% 0.88x 2.13x CN¥32.83 Million
2015 9.94% 8.63% 0.66x 1.75x CN¥-694.58K
2016 9.04% 7.79% 0.54x 2.15x CN¥-12.49 Million
2017 12.73% 9.48% 0.45x 2.99x CN¥38.72 Million
2018 7.35% 3.87% 0.57x 3.34x CN¥-39.93 Million
2019 8.03% 3.93% 0.63x 3.23x CN¥-30.63 Million
2020 4.84% 2.88% 0.52x 3.22x CN¥-78.16 Million
2021 -29.75% -13.40% 0.56x 3.94x CN¥-445.52 Million
2022 -39.62% -15.30% 0.51x 5.04x CN¥-398.11 Million
2023 -130.92% -22.27% 0.53x 11.12x CN¥-486.58 Million
2024 0.00% -54.37% 0.46x 0.00x CN¥-608.95 Million
2025 -249.25% -46.64% 0.75x 7.10x CN¥-436.52 Million

Industry Comparison

This section compares Chongqing Sansheng Building Materials Co Ltd's net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.

Industry Context

  • Industry: Drug Manufacturers - Specialty & Generic
  • Average net assets among peers: $3,632,988,841
  • Average return on equity (ROE) among peers: 4.16%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
Chongqing Sansheng Building Materials Co Ltd (002742) CN¥230.59 Million 21.86% 3.88x $358.38 Million
Shenzhen Neptunus Bioengineering Co Ltd (000078) $1.97 Billion 4.04% 0.54x $565.97 Million
Anhui Fengyuan Pharmaceutical Co Ltd (000153) $654.09 Million 2.17% 0.78x $359.03 Million
Shan Dong Dong-E E-Jiao Co Ltd (000423) $0.00 0.00% 0.00x $4.30 Billion
Livzon Pharmaceutical Group Inc (000513) $973.90 Million 0.17% 0.60x $2.52 Billion
Wedge Industrial Co Ltd (000534) $1.29 Billion 11.69% 1.47x $2.41 Billion
Yunnan Baiyao Group Co Ltd (000538) $3.19 Billion 14.61% 0.55x $12.64 Billion
Hainan Haiyao Co Ltd (000566) $353.98 Million -9.58% 0.80x $715.72 Million
Tus Pharmaceutical Group Co Ltd (000590) $307.22 Million 6.68% 0.79x $319.94 Million
Northeast Pharmaceutical Group Co Ltd (000597) $2.55 Billion 4.67% 3.16x $916.75 Million
Jilin Aodong Pharmaceutical Group Co Ltd (000623) $25.04 Billion 7.11% 0.16x $3.00 Billion

About Chongqing Sansheng Building Materials Co Ltd

SHE:002742 China Drug Manufacturers - Specialty & Generic
Market Cap
$358.38 Million
CN¥2.45 Billion CNY
Market Cap Rank
#14070 Global
#4207 in China
Share Price
CN¥3.58
Change (1 day)
-0.83%
52-Week Range
CN¥3.58 - CN¥6.00
All Time High
CN¥27.47
About

Chongqing Jiheng Pharmaceutical Co., Ltd. develops, produces and sells building materials and chemicals in China and internationally. It operates through two segments, Buildings Materials Chemical Industry; and Pharmaceutical Manufacturing. The company offers commercial concrete, water reducing agents, and expansion agents for industrial and civil buildings, highways, railways, bridges, tunnels, … Read more